Syngene International Shares Decline As Q4 Earnings Miss Estimates

Syngene International Shares Tank By over 10% After Q4 Earnings Miss

Syngene International (NSE: SYNGENE) saw its share price plunge by over 10% intraday on April 24, as investors reacted sharply to disappointing Q4 earnings. The biopharmaceutical services giant reported an 8% year-on-year decline in net profit, triggering a sell-off that saw the stock drop to an intraday low of ₹657.90 — its worst single-day performance in months. The company posted a net profit of ₹151 crore for Q4 FY24, down from ₹164 crore in…

Syngene International Shares Decline As Q4 Earnings Miss Estimates

Syngene International Ltd. saw a decline in its share price after announcing its fourth-quarter earnings. The company's financial performance for the quarter ending March 2025 fell short of market expectations, leading to a significant drop in market capitalisation.For the fourth quarter, Syngene reported an 11% increase in revenue, reaching Rs 1,018 crore, compared to Rs 917 crore in the same period last year. However, this was below the Bloomb…